U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...

Nektar Therapeutics is fairly valued based on rNPV modeling, but multiple near-term catalysts could drive upside. Learn why ...

Voters in Detroit and seven other communities across southeast Michigan are voting on candidates for mayor and other municipal offices.

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...